Drug-Induced Hemolytic Anemia – Decision Support Tool

Drug-Induced Hemolytic Anemia – Decision Support (HCP)

Drug-Induced Hemolytic Anemia – Decision Support (HCP)

Triage • Timing • Hemolysis evidence • Mechanism • Severity • Causality • Regulatory • Actions • Summary

1) Patient, Drug & Timing

Days start → onset

–

Risk window

–
Drug-class–informed

Known association

–
Penicillins, cephalosporins, quinidine, methyldopa, NSAIDs, oxidants (primaquine, dapsone, nitrofurantoin)

2) Hemolysis – Labs & Findings

Hemolysis evidence

–

Severity / urgency

–

Emergency flags

–
Suggested immediate actions:

    Mechanism • Causality • Regulatory • Alt. causes • Summary

    Mechanism lean

    –

    Timing class

    –
    Drug-class expectations

    Culprit class

    –

    Causality – Quick (WHO-UMC / Naranjo-inspired)

    Causality score: 0
    Result: –
    Auto adds +1 biologic plausibility if DAT positive or (G6PD deficient + oxidant drug).

    Regulatory Reporting – Reportability Aid

    Use label/IB per SOP.

    Reportability

    –

    Expedited timeline

    –
    Indicative; verify local rules/SOPs

    Due by (from awareness)

    –
    Many regions expedite serious + unexpected post-marketing cases (~15 days). In trials, serious + unexpected suspected reactions are SUSARs (fatal/life-threatening ~7 days; others ~15 days). Always follow your SOP/regional rules.

    Alternative explanations (checklist)

    • Infections (e.g., malaria), sepsis/DIC.
    • Autoimmune hemolytic anemia (primary; cold agglutinin disease).
    • Hereditary: sickle cell, thalassemia, hereditary spherocytosis.
    • MAHA (TTP/HUS), prosthetic valve/mechanical hemolysis.
    • G6PD deficiency (baseline) with non-drug triggers (e.g., fava beans).

    Auto-generated Case Summary

    Disclaimer: Decision support only; does not replace clinical judgment, specialist input, or local SOPs/regulations. Causality/urgency heuristics are simplified aids.